Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alaeldin Eltom

Interventional Cardiology Mesa, AZ Medical Doctor

NPI 1033373386 CMS profile 1374

10238 E Hampton Ave, Suite 501, Mesa, AZ 85209

Open in the dashboard

General payments

$3,868

234 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alaeldin Eltom of Mesa, AZ is reported in the CMS Open Payments database as having received $3,868 across 234 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 32nd percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19 1
2023 General $45 2
2022 General $219 10
2021 General $1,803 95
2020 General $606 47
2019 General $1,176 79

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alaeldin Eltom
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Alaeldin Eltom were reported at $19. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Alaeldin Eltom Interventional Cardiology median Middle half National median
2019 $1,176 $1,097 $329–$3,048 $163
2020 $606 $473 $161–$1,480 $114
2021 $1,803 $677 $233–$1,827 $132
2022 $219 $978 $333–$2,724 $149
2023 $45 $1,136 $382–$2,986 $160
2024 $0 $1,181 $395–$3,326 $164
2025 $19 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $2,732 169 payments
  2. Cardiovascular Systems Inc. $220 3 payments
  3. Amgen Inc. $177 13 payments
  4. AstraZeneca Pharmaceuticals LP $130 10 payments
  5. E.R. Squibb & Sons, L.L.C. $81 6 payments
  6. Janssen Pharmaceuticals, Inc $80 6 payments
  7. Pfizer Inc. $65 5 payments
  8. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $63 2 payments
  9. Abiomed $46 2 payments
  10. Amarin Pharma Inc. $43 3 payments
  11. Other $232 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,868 234 payments
Products named General payments · program years 2019–2025
  1. Xience Sierra Coronary Stent System Cardiac Arrhythmias and Heart Failure $889 67 payments
  2. Optis Coronary Imaging System $411 19 payments
  3. Xience Sierra Coronary Stent Vascular $405 24 payments
  4. Xience Sierra Coronary Stent System Vascular $391 27 payments
  5. Diamondback Peripheral $220 3 payments
  6. Repatha $177 13 payments
  7. Xience Sierra Coronary Stent Cardiac Arrhythmias and Heart Failure $144 13 payments
  8. Epic Stented Tissue Valve $108 2 payments
  9. BRILINTA $89 7 payments
  10. Confirm Rx $88 1 payment
  11. Other $1,085 68 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

234 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record